The most concerning aspect of this is that the myocarditis itself was “focal and mild, as is mostly observed following COVID-19 mRNA vaccination” yet this resulted in a fatal arrhythmia, because cells which are part of the electrical system were affected.
A new study performed on adolescents in Hong Kong who suffered myocarditis after mRNA injection in Circulation appears to be generating quite a lot of discussion over how common it is, and what the long-term outcomes are for those unfortunate enough to suffer from this side effect.
Although there have been several epidemiological analyses of myocarditis, that simple comparison is never made. Where uninjected people are looked at specifically, there is no evidence of an increase in incidence. HART has previously summarised the data after infection in the injected compared to the uninjected.
An alternative approach is to look at how common myocarditis is over time. Did the incidence increase with the arrival of covid in 2020 or the arrival of injections in 2021?
‘Myocarditis is more common after covid than after the vaccine’ is a statement often made in response to safety concerns raised but what is the evidence for these assertions?
Hart recently published an article summarising the results of a study performed in the US military which found that nearly 3% of those vaccinated with smallpox vaccine developed subclinical myocarditis (defined by an increased troponin level – which was prospectively measured in all subjects).
We, the undersigned, are writing to express our deep concern at the guidance regarding further mRNA vaccination after any episode of myocarditis, as detailed in the UKHSA guidance for healthcare professionals.
In 2015 a team of researchers employed by the medical services of the US military published a peer-reviewed paper on the incidence of myocarditis and pericarditis after smallpox vaccination (SPX) and vaccination with an inactivated trivalent influenza vaccine (TIV).
Two new studies on myocarditis / pericarditis after mRNA vaccination have been published in major peer-reviewed journals.
Both are based on very large population samples. Both these studies find significantly higher rates of myocarditis, especially in younger males, than governments have to date acknowledged publicly.
The official narrative claims that vaccines prevent infection and therefore reduce risk of myocarditis from infection. This claim is reliant on two points: 1. Vaccines reducing infections 2. That infection related myocarditis occurs at a lower rate in the vaccinated.
20 August 2021 – The roll out of the COVID-19 vaccine to adolescents has begun, despite evidence that myocarditis is a side effect of the vaccine.
Our drug safety monitoring systems are designed to identify an increase in the incidence of a rare condition. That is why they worked relatively well at identifying the Cerebral Venous Sinus Thrombosis and myocarditis cases. They are bad at identifying increases in more common conditions and terrible at identifying multi-system conditions.
A letter to a Professor who has yet to learn the reality of vaccine injury the hard way.
This week we cover delayed Pfizer reports on cardiac adverse events, Moderna lying to the regulators, and a lifeline campaign for the vaccine injured.
In August 2021, the JCVI said they wanted to delay a decision about children’s covid vaccines until 6-month followup data was available on children from the US who had sustained vaccine-induced myocarditis. But instead of waiting, they passed the decision to the Chief Medical Officers, who decided the jabs would be good for children’s mental health! Well the data is now in and it is not encouraging.
CCVAC members wrote to the four Chief Medical Officers in Septmeber 2021 to counsel against approving covid-19 vaccines for use in healthy children without waiting for cardiac followup studies. We have written again to point to the 60% ongoing cardiac damage in those suffering vaccine-induced myocarditis
It is a question of ‘when’ not ‘if’ the next pandemic is ‘declared’, and then a question of how many people will say, “fool me once, shame on you, fool me twice, shame on me.”
On 18th April, Andrew Bridgen finally secured a full length debate on this vexed topic, the original text of which is available here. Full length in theory, but shortly before the debate was due to begin, the deputy Speaker told him he only had 15 minutes instead of the 30 minutes he had prepared. After a complaint to the Speaker’s office the compromise was 20 minutes.
The MHRA are far too slow to react to harm and admit causation. There is a history here. When the 2009 swine flu vaccine caused narcolepsy the UK institutions were very slow to react. It was Scandinavian countries who highlighted the problem in 2010. That year the MHRA were measuring for other effects but not narcolepsy. In 2011, they said they needed to await epidemiological studies. It took until 2013 before Public Health England admitted a problem in the UK.
